Phase 2Recruiting
Repositioning Immunotherapy in VetArans With Lung Cancer
Sponsored by VA Office of Research and Development
About this study
This study is a multicenter Phase II single arm trial to assess the safety and efficacy of chemotherapy and immunotherapy followed by radiotherapy in patients with unresectable Stage III NSCLC.
Enrolling at this location
Richmond VA Medical Center, Richmond, VA
Richmond, Virginia
I'm interestedThis study also enrolls at 6 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.